THE THERAPEUTIC EFFECTS OF MAGNETIC NANOPARTICLES HYPERTHERMIA ON LIVER CANCER : IN VITRO AND IN VIVO STUDIES

Hassan, Hemely A.; Ebnalwaled, Khaled; Gedawy, Huda Y.; Mahrous, Nadia S.

doi:10.21608/ejz.2023.224673.1101

	THE THERAPEUTIC EFFECTS OF MAGNETIC NANOPARTICLES HYPERTHERMIA ON LIVER CANCER : IN VITRO AND IN VIVO STUDIES
Egyptian Journal of Zoology
Article 30, Volume 81, Issue 81, June 2024, Page 76-90 PDF (789.84 K)
Document Type: Original Research Papers
DOI: 10.21608/ejz.2023.224673.1101
View on SCiNiTO
Authors
Hemely A. Hassan¹; Khaled Ebnalwaled²^{, 3}; Huda Y. Gedawy¹; Nadia S. Mahrous ¹
¹Zoology Department, Faculty of Science, South Valley University, Qena, Egypt
²Electronics and Nano Devices Lab, Physics Department, Faculty of Science, South Valley University, Qena, Egypt
³Faculty of Nanotechnology for Postgraduate Studies, Cairo University, Sheikh Zayed Campus, Giza, Egypt
Abstract
Magnetic fluid hyperthermia is a modern cancer treatment that selectively heats tumor tissues to destroy them without harming healthy tissues. The current study aimed to evaluate the cytotoxic effect of Fe₃O₄/chitosan nanocomposite hyperthermia on liver cancer both in vitro and in vivo. The nanocomposite was prepared using the co-precipitation technique; and its magnetic and optical properties were measured along with its Raman spectrum. Cell toxicity for Fe₃O₄/chitosan nanocomposite was conducted on a liver cancer cell line (HepG2) using 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) assay, and the cell viability was performed after exposure to Fe₃O₄/chitosan nanocomposite hyperthermia using trypan blue stain. For the in vivo experiments, 25 male BALB/c albino micewere randomly/equally allotted into five groups: the 1^st group was the non-tumor control group, the 2^ndgroup involved the tumor-bearing control mice, the 3^rd group involved the tumor-bearing mice received intramuscular injection of Fe₃O₄/chitosan (90 mg/kg, once/week for two weeks), the 4^th and 5^th groups involved tumor-bearing mice received intramuscular injection of Fe₃O₄/chitosan and exposed to an alternating magnetic field with a frequency of "200 kHz" and an output current of "300 A" once or twice/week, respectively, for two weeks. The results showed that nanocomposite was able to induce cytotoxicity (in vitro), as well as enhanced programmed cell death and necrosis of tumor cells, and reduced significantly (P<0.05) the tumor size (in vivo), when exposed to a hyperthermal magnetic field. In conclusion, Fe₃O₄/chitosan nanocomposite could be a promising therapeutic option for liver cancer through magnetic heating technology.
Keywords
Apoptosis; Fe3O4/chitosan nanocomposite; HepG2; Magnetic hyperthermia; P53


Statistics Article View: 302 PDF Download: 445